Data:
{
"symbol": "EXEL",
"price": 58.49,
"marketCap": 14701758805,
"beta": 0.422,
"lastDividend": 0,
"range": "33.76-59.72",
"change": 1.71,
"changePercentage": 3.01163,
"volume": 1687787,
"averageVolume": 2513355,
"companyName": "Exelixis, Inc.",
"currency": "USD",
"cik": "0000939767",
"isin": "US30161Q1040",
"cusip": "30161Q104",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.exelixis.com",
"description": "Exelixis, Inc. operates as a biotechnology firm dedicated to combating cancer, primarily focusing on the identification, advancement, and marketing of novel oncological treatments within the United States. Its portfolio of commercially available therapeutics includes CABOMETYX tablets, prescribed for individuals with advanced renal cell carcinoma who have previously undergone anti-angiogenic treatment, and COMETRIQ capsules, utilized for managing progressive and metastatic medullary thyroid cancer. Both CABOMETYX and COMETRIQ originate from cabozantinib, a compound that inhibits several tyrosine kinases such as MET, AXL, RET, and VEGF receptors. Additionally, Exelixis offers COTELLIC, an MEK inhibitor employed in combination therapies for advanced melanoma, and MINNEBRO, an orally administered, non-steroidal selective mineralocorticoid receptor blocker, approved for hypertension treatment in Japan. The company's developmental pipeline features several promising candidates, such as XL092, an oral tyrosine kinase inhibitor designed to target VEGF receptors, MET, AXL, MER, and other kinases crucial for cancer proliferation; XB002, an antibody-drug conjugate containing a human monoclonal antibody against tissue factor (TF), intended for advanced solid tumors and non-Hodgkin's lymphoma; and XL102, an orally available cyclin-dependent kinase 7 (CDK7) inhibitor being developed for advanced or metastatic solid tumors. Exelixis, Inc. maintains extensive research partnerships and licensing arrangements with numerous pharmaceutical and biotechnology entities, including Ipsen Pharma SAS, Takeda Pharmaceutical Company Ltd., F. Hoffmann-La Roche Ltd., Redwood Bioscience, Inc., R.P. Scherer Technologies, LLC, Catalent Pharma Solutions, Inc., NBE Therapeutics AG, Aurigene Discovery Technologies Limited, Iconic Therapeutics, Inc., Invenra, Inc., StemSynergy Therapeutics, Inc., Genentech, Inc., Bristol-Myers Squibb Company, and Daiichi Sankyo Company, Limited. Established in 1994, the company originally operated as Exelixis Pharmaceuticals, Inc. before rebranding to Exelixis, Inc. in February 2000. Its corporate headquarters are located in Alameda, California.",
"ceo": "Michael Morrissey",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "1077",
"phone": "650 837 7000",
"address": "1851 Harbor Bay Parkway",
"city": "Alameda",
"state": "CA",
"zip": "94502",
"image": "https://images.financialmodelingprep.com/symbol/EXEL.png",
"ipoDate": "2000-04-17",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "EXEL",
"name": "Exelixis, Inc.",
"price": 58.49,
"changePercentage": 3.01163,
"change": 1.71,
"volume": 1687787,
"dayLow": 57.275,
"dayHigh": 58.52,
"yearHigh": 59.72,
"yearLow": 33.76,
"marketCap": 14701758805,
"priceAvg50": 55.3168,
"priceAvg200": 48.15605,
"exchange": "NASDAQ",
"open": 57.275,
"previousClose": 56.78,
"timestamp": 1789675201,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-07",
"v": 53.6743,
"c": 54.07
},
{
"t": "2026-08-10",
"v": 52.9968,
"c": 52.96
},
{
"t": "2026-08-11",
"v": 51.7503,
"c": 51.33
},
{
"t": "2026-08-12",
"v": 50.6764,
"c": 50.38
},
{
"t": "2026-08-13",
"v": 50.6602,
"c": 50.61
},
{
"t": "2026-08-14",
"v": 51.0357,
"c": 51.24
},
{
"t": "2026-08-17",
"v": 52.2518,
"c": 52.32
},
{
"t": "2026-08-18",
"v": 53.0369,
"c": 53.12
},
{
"t": "2026-08-19",
"v": 54.2787,
"c": 54.39
},
{
"t": "2026-08-20",
"v": 53.8769,
"c": 53.69
},
{
"t": "2026-08-21",
"v": 54.1794,
"c": 54.08
},
{
"t": "2026-08-24",
"v": 54.397,
"c": 54.55
},
{
"t": "2026-08-25",
"v": 56.3242,
"c": 56.72
},
{
"t": "2026-08-26",
"v": 56.4623,
"c": 56.1
},
{
"t": "2026-08-27",
"v": 55.2602,
"c": 55.26
},
{
"t": "2026-08-28",
"v": 54.4431,
"c": 54.45
},
{
"t": "2026-08-31",
"v": 54.5066,
"c": 54.64
},
{
"t": "2026-09-01",
"v": 56.2034,
"c": 56.89
},
{
"t": "2026-09-02",
"v": 58.0589,
"c": 58.53
},
{
"t": "2026-09-03",
"v": 59.1896,
"c": 59.13
},
{
"t": "2026-09-04",
"v": 58.9767,
"c": 59.01
},
{
"t": "2026-09-08",
"v": 58.1451,
"c": 57.67
},
{
"t": "2026-09-09",
"v": 58.0167,
"c": 58.33
},
{
"t": "2026-09-10",
"v": 57.5629,
"c": 57.43
},
{
"t": "2026-09-11",
"v": 56.1,
"c": 56.12
},
{
"t": "2026-09-14",
"v": 56.3028,
"c": 56.21
},
{
"t": "2026-09-15",
"v": 56.4519,
"c": 56.9
},
{
"t": "2026-09-16",
"v": 56.9989,
"c": 56.78
},
{
"t": "2026-09-17",
"v": 58.1819,
"c": 58.49
}
],
"vwap_summary": {
"days": 29,
"days_above": 16,
"days_below": 13,
"pct_days_above": 55,
"position": "above",
"gap_pct": 0.53,
"streak_days": 1
}
}
Data:
{
"volume": 1687787,
"avgVolume": 2513355,
"short_ratio": [
{
"symbol": "EXEL",
"file_date": "2026-09-17",
"date": "20260917",
"short_volume": 291803,
"short_exempt_volume": 13974,
"total_volume": 533357,
"short_volume_ratio": 0.5471,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 56.21,
"vah": 59.63,
"val": 55.55,
"profile": [
{
"price": 53.56,
"volume": 129950
},
{
"price": 53.66,
"volume": 196905
},
{
"price": 53.77,
"volume": 259875
},
{
"price": 53.87,
"volume": 253347
},
{
"price": 53.97,
"volume": 443858
},
{
"price": 54.07,
"volume": 530311
},
{
"price": 54.17,
"volume": 631846
},
{
"price": 54.28,
"volume": 797233
},
{
"price": 54.38,
"volume": 760041
},
{
"price": 54.48,
"volume": 872844
},
{
"price": 54.58,
"volume": 552264
},
{
"price": 54.68,
"volume": 379025
},
{
"price": 54.79,
"volume": 91100
},
{
"price": 54.89,
"volume": 7899
},
{
"price": 54.99,
"volume": 188607
},
{
"price": 55.09,
"volume": 265823
},
{
"price": 55.19,
"volume": 271672
},
{
"price": 55.3,
"volume": 400354
},
{
"price": 55.4,
"volume": 490476
},
{
"price": 55.5,
"volume": 464412
},
{
"price": 55.6,
"volume": 318435
},
{
"price": 55.7,
"volume": 123912
},
{
"price": 55.81,
"volume": 300482
},
{
"price": 55.91,
"volume": 207670
},
{
"price": 56.01,
"volume": 522009
},
{
"price": 56.11,
"volume": 927257
},
{
"price": 56.21,
"volume": 1307111
},
{
"price": 56.32,
"volume": 1027957
},
{
"price": 56.42,
"volume": 705701
},
{
"price": 56.52,
"volume": 659927
},
{
"price": 56.62,
"volume": 358390
},
{
"price": 56.72,
"volume": 1022003
},
{
"price": 56.83,
"volume": 794501
},
{
"price": 56.93,
"volume": 589205
},
{
"price": 57.03,
"volume": 189830
},
{
"price": 57.13,
"volume": 243815
},
{
"price": 57.23,
"volume": 402367
},
{
"price": 57.34,
"volume": 364474
},
{
"price": 57.44,
"volume": 457701
},
{
"price": 57.54,
"volume": 495329
},
{
"price": 57.64,
"volume": 315536
},
{
"price": 57.74,
"volume": 709169
},
{
"price": 57.85,
"volume": 367569
},
{
"price": 57.95,
"volume": 840477
},
{
"price": 58.05,
"volume": 548110
},
{
"price": 58.15,
"volume": 331181
},
{
"price": 58.25,
"volume": 298067
},
{
"price": 58.36,
"volume": 555816
},
{
"price": 58.46,
"volume": 515875
},
{
"price": 58.56,
"volume": 711125
},
{
"price": 58.66,
"volume": 316648
},
{
"price": 58.76,
"volume": 220922
},
{
"price": 58.87,
"volume": 156663
},
{
"price": 58.97,
"volume": 615273
},
{
"price": 59.07,
"volume": 900926
},
{
"price": 59.17,
"volume": 285813
},
{
"price": 59.27,
"volume": 141437
},
{
"price": 59.38,
"volume": 185877
},
{
"price": 59.48,
"volume": 261807
},
{
"price": 59.58,
"volume": 188780
}
],
"sessions": 20
}
}
Data:
{
"symbol": "EXEL",
"marketCap": 14701758805,
"enterpriseValueTTM": 14586239805,
"evToSalesTTM": 5.987979820765871,
"evToOperatingCashFlowTTM": 12.325465877374363,
"evToFreeCashFlowTTM": 12.594050004964664,
"evToEBITDATTM": 14.025176638743698,
"netDebtToEBITDATTM": -0.11107553432486798,
"currentRatioTTM": 3.4560063217168104,
"incomeQualityTTM": 1.3750771243622353,
"grahamNumberTTM": 23.823676223354465,
"grahamNetNetTTM": 1.8110955392172499,
"taxBurdenTTM": 0.831145590487761,
"interestBurdenTTM": 1.0164702048124648,
"workingCapitalTTM": 888895000,
"investedCapitalTTM": 1293172000,
"returnOnAssetsTTM": 0.3450450118152507,
"operatingReturnOnAssetsTTM": 0.38189623978959975,
"returnOnTangibleAssetsTTM": 0.35408570076731605,
"returnOnEquityTTM": 0.4249188023643438,
"returnOnInvestedCapitalTTM": 0.3786823772375907,
"returnOnCapitalEmployedTTM": 0.4556149747667667,
"earningsYieldTTM": 0.05866646793767025,
"freeCashFlowYieldTTM": 0.07877866963822769,
"capexToOperatingCashFlowTTM": 0.021326271333242636,
"capexToDepreciationTTM": 0.8918021201413427,
"capexToRevenueTTM": 0.010360767184472397,
"salesGeneralAndAdministrativeToRevenueTTM": 0.21918576964760747,
"researchAndDevelopementToRevenueTTM": 0.3383998653486157,
"stockBasedCompensationToRevenueTTM": 0.04622278235738448,
"intangiblesToTotalAssetsTTM": 0.025532488130624472,
"averageReceivablesTTM": 331780000,
"averagePayablesTTM": 31608000,
"averageInventoryTTM": 27667000,
"daysOfSalesOutstandingTTM": 50.13865192617163,
"daysOfPayablesOutstandingTTM": 166.43471662872818,
"daysOfInventoryOutstandingTTM": 122.4080429580342,
"operatingCycleTTM": 172.54669488420583,
"cashConversionCycleTTM": 6.111978255477652,
"freeCashFlowToEquityTTM": 1172459000,
"freeCashFlowToFirmTTM": 1172459000,
"tangibleAssetValueTTM": 1780078000,
"netCurrentAssetValueTTM": 600350000,
"grossProfitMarginTTM": 0.9648325889191763,
"ebitMarginTTM": 0.41819435777858055,
"ebitdaMarginTTM": 0.42694505566685276,
"operatingProfitMarginTTM": 0.39882713718020296,
"pretaxProfitMarginTTM": 0.4250821045026109,
"continuousOperationsProfitMarginTTM": 0.35330511675260273,
"netProfitMarginTTM": 0.35330511675260273,
"bottomLineProfitMarginTTM": 0.35330511675260273,
"receivablesTurnoverTTM": 7.279812798665922,
"payablesTurnoverTTM": 2.19305207106651,
"inventoryTurnoverTTM": 2.9818302064116398,
"fixedAssetTurnoverTTM": 7.151996664640788,
"assetTurnoverTTM": 0.9766204774692351,
"quickRatioTTM": 3.3766284361210963,
"solvencyRatioTTM": 1.3558446789408307,
"cashRatioTTM": 0.7776374793812012,
"priceToEarningsRatioTTM": 17.778115501519757,
"priceToEarningsGrowthRatioTTM": 0.33082754063697634,
"forwardPriceToEarningsGrowthRatioTTM": 0.9855195034981366,
"priceToEarningsDilutedRatioTTM": 18.335423197492165,
"priceToEarningsDilutedGrowthRatioTTM": 0.33887791088222113,
"priceToBookRatioTTM": 7.956428172399692,
"priceToSalesRatioTTM": 6.035402970951427,
"priceToFreeCashFlowRatioTTM": 12.693791410698635,
"priceToOperatingCashFlowRatioTTM": 12.396040908449473,
"debtToAssetsRatioTTM": 0.0665250333368882,
"debtToEquityRatioTTM": 0.08999480410161398,
"debtToCapitalRatioTTM": 0.08256443403488396,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.35279607671706,
"workingCapitalTurnoverRatioTTM": 2.8217081741292063,
"operatingCashFlowRatioTTM": 3.269783685660368,
"operatingCashFlowSalesRatioTTM": 0.4858217839666327,
"freeCashFlowOperatingCashFlowRatioTTM": 0.9786737286667574,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": 7.132104695381759,
"capitalExpenditureCoverageRatioTTM": 46.89052222838577,
"dividendPaidAndCapexCoverageRatioTTM": 46.89052222838577,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 9.712289879110713,
"netIncomePerShareTTM": 3.431401709674333,
"interestDebtPerShareTTM": 0.6615777806130586,
"cashPerShareTTM": 3.3467233900035085,
"bookValuePerShareTTM": 7.351288635131255,
"tangibleBookValuePerShareTTM": 7.097373289528245,
"shareholdersEquityPerShareTTM": 7.351288635131255,
"operatingCashFlowPerShareTTM": 4.718441995470639,
"capexPerShareTTM": 0.10062677426557366,
"freeCashFlowPerShareTTM": 4.617815221205065,
"netIncomePerEBTTTM": 0.831145590487761,
"ebtPerEbitTTM": 1.0658304435050143,
"priceToFairValueTTM": 7.956428172399692,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0.16885440951223893,
"enterpriseValueMultipleTTM": 14.025176638743698,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 2168701000
},
{
"date": "2026",
"revenue": 2320126000
}
],
"dcf": {
"symbol": "EXEL",
"date": "2026-09-17",
"dcf": 152.63400057499112,
"Stock Price": 57.84
},
"statements": {
"income": [
{
"date": "2026-01-02",
"symbol": "EXEL",
"reportedCurrency": "USD",
"cik": "0000939767",
"filingDate": "2026-02-10",
"acceptedDate": "2026-02-10 16:32:29",
"fiscalYear": "2025",
"period": "FY",
"revenue": 2320126000,
"costOfRevenue": 83697000,
"grossProfit": 2236429000,
"researchAndDevelopmentExpenses": 825001000,
"generalAndAdministrativeExpenses": 467027000,
"sellingAndMarketingExpenses": 51700000,
"sellingGeneralAndAdministrativeExpenses": 518727000,
"otherExpenses": 20510000,
"operatingExpenses": 1364238000,
"costAndExpenses": 1447935000,
"netInterestIncome": 69213000,
"interestIncome": 69213000,
"interestExpense": 0,
"depreciationAndAmortization": 29055000,
"ebitda": 921756000,
"ebit": 892701000,
"nonOperatingIncomeExcludingInterest": -20510000,
"operatingIncome": 872191000,
"totalOtherIncomeExpensesNet": 69015000,
"incomeBeforeTax": 941206000,
"incomeTaxExpense": 158636000,
"netIncomeFromContinuingOperations": 782570000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 782570000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 782570000,
"eps": 2.88,
"epsDiluted": 2.78,
"weightedAverageShsOut": 271567000,
"weightedAverageShsOutDil": 281863000
}
],
"balance_sheet": [
{
"date": "2026-01-02",
"symbol": "EXEL",
"reportedCurrency": "USD",
"cik": "0000939767",
"filingDate": "2026-02-10",
"acceptedDate": "2026-02-10 16:32:29",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 482488000,
"shortTermInvestments": 576603000,
"cashAndShortTermInvestments": 1059091000,
"netReceivables": 286916000,
"accountsReceivables": 286916000,
"otherReceivables": 0,
"inventory": 21686000,
"prepaids": 0,
"otherCurrentAssets": 75596000,
"totalCurrentAssets": 1443289000,
"propertyPlantEquipmentNet": 441265000,
"goodwill": 63684000,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 63684000,
"longTermInvestments": 603603000,
"taxAssets": 292582000,
"otherNonCurrentAssets": 0,
"totalNonCurrentAssets": 1401134000,
"otherAssets": 0,
"totalAssets": 2844423000,
"totalPayables": 29623000,
"accountPayables": 29623000,
"otherPayables": 0,
"accruedExpenses": 88525000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 287496000,
"totalCurrentLiabilities": 405644000,
"longTermDebt": 0,
"capitalLeaseObligationsNonCurrent": 173038000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 104422000,
"totalNonCurrentLiabilities": 277460000,
"otherLiabilities": 0,
"capitalLeaseObligations": 173038000,
"totalLiabilities": 683104000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 262000,
"retainedEarnings": -76830000,
"additionalPaidInCapital": 2234411000,
"accumulatedOtherComprehensiveIncomeLoss": 3476000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 2161319000,
"totalEquity": 2161319000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 2844423000,
"totalInvestments": 1180206000,
"totalDebt": 173038000,
"netDebt": -309450000
}
],
"cash_flow": [
{
"date": "2026-01-02",
"symbol": "EXEL",
"reportedCurrency": "USD",
"cik": "0000939767",
"filingDate": "2026-02-10",
"acceptedDate": "2026-02-10 16:32:29",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 782570000,
"depreciationAndAmortization": 29055000,
"deferredIncomeTax": 126237000,
"stockBasedCompensation": 112983000,
"changeInWorkingCapital": -191197000,
"accountsReceivables": -21398000,
"inventory": 12225000,
"accountsPayables": -50152000,
"otherWorkingCapital": -131872000,
"otherNonCashItems": 24619000,
"netCashProvidedByOperatingActivities": 884267000,
"investmentsInPropertyPlantAndEquipment": -8429000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -632497000,
"salesMaturitiesOfInvestments": 1022866000,
"otherInvestingActivities": -31499000,
"netCashProvidedByInvestingActivities": 350441000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -898374000,
"netCommonStockIssuance": -898374000,
"commonStockIssuance": 49137000,
"commonStockRepurchased": -947511000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -71220000,
"netCashProvidedByFinancingActivities": -969594000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 265114000,
"cashAtEndOfPeriod": 482488000,
"cashAtBeginningOfPeriod": 217374000,
"operatingCashFlow": 884267000,
"capitalExpenditure": -39928000,
"freeCashFlow": 844339000,
"incomeTaxesPaid": 155296000,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 58.49,
"rsi": 59.67883063074198,
"sma20": 56.54899999999998,
"sma50": 55.36440000000004,
"sma200": 48.22765000000002,
"adx": 15.550828363700532,
"atr": 1.67,
"atr_pct": 2.86,
"atr_expansion_pct": 10.9,
"di_plus": 26.7,
"di_minus": 28.0,
"high_52w": 59.13,
"low_52w": 34.54,
"structure": {
"ema8": 57.26621196799744,
"ema21": 56.47838964704385,
"ema50": 55.1611534034716,
"ema200": 49.34594788404173,
"ema10": 57.16089678750695,
"ema20": 56.53543370381748,
"ema10_slope_pct": -0.13,
"ema20_slope_pct": 0.55,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 3.6,
"_no_bars": false,
"macd": {
"macd": 0.814,
"signal": 0.807,
"histogram": 0.007
},
"bollinger": {
"mid": 56.55,
"upper": 59.85,
"lower": 53.25,
"width_pct": 11.67
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": false,
"candles_since": 16,
"intraday_support": false
},
"momentum": {
"roc10": -0.1,
"ret_3d": 4.06,
"ret_5d": 1.85,
"roc10_accel": -2.44,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.83,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -2.27,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": false
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 147006133.95000002
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": true,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.8,
"iv_rank": 31.0
}
}
}
}
Data:
{
"prior_day": {
"high": 58.52,
"low": 57.23,
"close": 58.49,
"date": "2026-09-17"
},
"woodie_pivots": {
"PP": 58.18,
"R1": 59.14,
"S1": 57.85,
"R2": 59.47,
"S2": 56.89
},
"swing": {
"high_20d": 59.72,
"low_20d": 53.39,
"high_60d": 59.72,
"low_60d": 49.97
},
"orb": {
"high": 57.89,
"low": 57.23,
"date": "2026-09-17"
},
"vwap": 58.0,
"volume_profile": {
"poc": 56.21,
"vah": 59.63,
"val": 55.55,
"sessions": 20
},
"intraday": {
"h1_trend": "up",
"h1_last": 58.12,
"h1_ema9": 57.77,
"h1_ema21": 57.37,
"m15_trend": "up",
"m15_last": 58.15,
"m15_ema9": 58.03,
"m15_ema21": 57.92,
"rvol_intraday": 0.74,
"as_of_et": "2026-09-17 15:55"
},
"premarket": {
"date": "2026-09-17",
"high": 57.5,
"low": 56.75,
"last": 57.5,
"volume": 2376,
"gap_pct": 1.27,
"path": "04:15 56.75 -> 07:00 56.91 -> 09:25 57.50",
"bars": 3,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-08-13",
"o": 50.54,
"h": 51.14,
"l": 49.97,
"c": 50.61,
"v": 1948740.655217
},
{
"d": "2026-08-14",
"o": 50.32,
"h": 51.29,
"l": 50.02,
"c": 51.24,
"v": 2342519.8399
},
{
"d": "2026-08-17",
"o": 51.25,
"h": 52.7,
"l": 50.805,
"c": 52.32,
"v": 2372576.008202
},
{
"d": "2026-08-18",
"o": 52.32,
"h": 53.36,
"l": 52.11,
"c": 53.12,
"v": 1290526.453808
},
{
"d": "2026-08-19",
"o": 53.46,
"h": 54.58,
"l": 53.1,
"c": 54.39,
"v": 2503640.830712
},
{
"d": "2026-08-20",
"o": 53.76,
"h": 54.5,
"l": 53.44,
"c": 53.69,
"v": 1950664.12645
},
{
"d": "2026-08-21",
"o": 53.74,
"h": 54.68,
"l": 53.7,
"c": 54.08,
"v": 1949764.528563
},
{
"d": "2026-08-24",
"o": 53.89,
"h": 54.79,
"l": 53.39,
"c": 54.55,
"v": 2423091.367099
},
{
"d": "2026-08-25",
"o": 54.95,
"h": 56.74,
"l": 54.95,
"c": 56.72,
"v": 2024358.692281
},
{
"d": "2026-08-26",
"o": 56.54,
"h": 56.9,
"l": 56.06,
"c": 56.1,
"v": 1816723.591412
},
{
"d": "2026-08-27",
"o": 55.76,
"h": 56.08,
"l": 54.83,
"c": 55.26,
"v": 1489697.521922
},
{
"d": "2026-08-28",
"o": 55.14,
"h": 55.25,
"l": 54.12,
"c": 54.45,
"v": 1486617.174289
},
{
"d": "2026-08-31",
"o": 54.1,
"h": 55.02,
"l": 53.4283,
"c": 54.64,
"v": 2246348.227287
},
{
"d": "2026-09-01",
"o": 54.75,
"h": 56.97,
"l": 54.75,
"c": 56.89,
"v": 2413531.209294
},
{
"d": "2026-09-02",
"o": 57.21,
"h": 59.11,
"l": 56.695,
"c": 58.53,
"v": 2851454.179068
},
{
"d": "2026-09-03",
"o": 58.75,
"h": 59.72,
"l": 58.195,
"c": 59.13,
"v": 2141585.361595
},
{
"d": "2026-09-04",
"o": 58.502,
"h": 59.255,
"l": 58.455,
"c": 59.01,
"v": 1580988.569775
},
{
"d": "2026-09-08",
"o": 58.97,
"h": 59.41,
"l": 57.55,
"c": 57.67,
"v": 2538923.348388
},
{
"d": "2026-09-09",
"o": 57.6,
"h": 58.36,
"l": 56.95,
"c": 58.33,
"v": 1770279.650293
},
{
"d": "2026-09-10",
"o": 58.33,
"h": 58.33,
"l": 57.23,
"c": 57.43,
"v": 1789572.768951
},
{
"d": "2026-09-11",
"o": 56.76,
"h": 57.43,
"l": 54.545,
"c": 56.12,
"v": 2916863.918572
},
{
"d": "2026-09-14",
"o": 56.44,
"h": 57.07,
"l": 55.91,
"c": 56.21,
"v": 1739463.92889
},
{
"d": "2026-09-15",
"o": 55.93,
"h": 56.97,
"l": 54.945,
"c": 56.9,
"v": 1980448.588606
},
{
"d": "2026-09-16",
"o": 57.04,
"h": 57.78,
"l": 56.325,
"c": 56.78,
"v": 1879641.306587
},
{
"d": "2026-09-17",
"o": 57.23,
"h": 58.52,
"l": 57.23,
"c": 58.49,
"v": 1785586.674802
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 1.9,
"etf_rvol": 0.68,
"rs_5d": -0.06,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "EXEL",
"date": "2031-01-02",
"revenueLow": 2912538247,
"revenueHigh": 3302887293,
"revenueAvg": 3149089744,
"ebitdaLow": 1638985493,
"ebitdaHigh": 1909780349,
"ebitdaAvg": 1803087651,
"ebitLow": 1516370889,
"ebitHigh": 1787165745,
"ebitAvg": 1680473047,
"netIncomeLow": 1202875724,
"netIncomeHigh": 1417686336,
"netIncomeAvg": 1333051332,
"sgaExpenseLow": 764488634,
"sgaExpenseHigh": 866948202,
"sgaExpenseAvg": 826579126,
"epsAvg": 4.72943,
"epsHigh": 5.0297,
"epsLow": 4.26759,
"numAnalystsRevenue": 6,
"numAnalystsEps": 5
},
{
"symbol": "EXEL",
"date": "2030-01-02",
"revenueLow": 3252014832,
"revenueHigh": 3687861773,
"revenueAvg": 3516138050,
"ebitdaLow": 1924283142,
"ebitdaHigh": 2248074353,
"ebitdaAvg": 2120499352,
"ebitLow": 1813129162,
"ebitHigh": 2136920373,
"ebitAvg": 2009345372,
"netIncomeLow": 1438282065,
"netIncomeHigh": 1695132543,
"netIncomeAvg": 1593932452,
"sgaExpenseLow": 853595101,
"sgaExpenseHigh": 967997043,
"sgaExpenseAvg": 922922670,
"epsAvg": 5.65499,
"epsHigh": 6.01403,
"epsLow": 5.10277,
"numAnalystsRevenue": 7,
"numAnalystsEps": 4
},
{
"symbol": "EXEL",
"date": "2029-01-02",
"revenueLow": 2442001801,
"revenueHigh": 3568173632,
"revenueAvg": 3252916350,
"ebitdaLow": 1472194740,
"ebitdaHigh": 2345222204,
"ebitdaAvg": 1624383338,
"ebitLow": 1380275252,
"ebitHigh": 2253302716,
"ebitAvg": 1532463850,
"netIncomeLow": 1094916557,
"netIncomeHigh": 1787453951,
"netIncomeAvg": 1215641620,
"sgaExpenseLow": 640981324,
"sgaExpenseHigh": 936581070,
"sgaExpenseAvg": 853831733,
"epsAvg": 4.97104,
"epsHigh": 6.34157,
"epsLow": 3.88457,
"numAnalystsRevenue": 14,
"numAnalystsEps": 8
},
{
"symbol": "EXEL",
"date": "2028-01-02",
"revenueLow": 2798466057,
"revenueHigh": 2970974238,
"revenueAvg": 2894303936,
"ebitdaLow": 1363807656,
"ebitdaHigh": 1805470012,
"ebitdaAvg": 1432545567,
"ebitLow": 1292411095,
"ebitHigh": 1734073451,
"ebitAvg": 1361149006,
"netIncomeLow": 1025217474,
"netIncomeHigh": 1375570366,
"netIncomeAvg": 1079744480,
"sgaExpenseLow": 734546747,
"sgaExpenseHigh": 779827025,
"sgaExpenseAvg": 759702457,
"epsAvg": 4.14671,
"epsHigh": 4.88028,
"epsLow": 3.63729,
"numAnalystsRevenue": 13,
"numAnalystsEps": 9
}
],
"price_target": {
"symbol": "EXEL",
"targetHigh": 56,
"targetLow": 46,
"targetConsensus": 51.78,
"targetMedian": 52
},
"ratings": {
"symbol": "EXEL",
"rating": "A-",
"overallScore": 4,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 3,
"priceToEarningsScore": 2,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "EXEL",
"date": "2026-08-19",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-08-06",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-08-06",
"gradingCompany": "Stifel",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-23",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-14",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-13",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-07-02",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-06-25",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "EXEL",
"date": "2026-06-24",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-05-07",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-05-06",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-05-06",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-05-06",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-05-06",
"gradingCompany": "Stifel",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-04-20",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-03-02",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-12",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-11",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-11",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-11",
"gradingCompany": "Stifel",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-04",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-03",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-02-02",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-01-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2026-01-08",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Equal Weight",
"action": "downgrade"
},
{
"symbol": "EXEL",
"date": "2026-01-08",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-11-06",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-11-05",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-11-05",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-11-05",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-11-05",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-11-03",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "EXEL",
"date": "2025-10-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-10-21",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-10-21",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "EXEL",
"date": "2025-10-21",
"gradingCompany": "Leerink Partners",
"previousGrade": "Market Perform",
"newGrade": "Outperform",
"action": "upgrade"
}
]
}
Data:
[
{
"title": "Exelixis Eyes Oncology Deals, Readies Zanzalintinib Launch as Cabozantinib Tops $3B",
"url": "https://www.marketbeat.com/instant-alerts/event-exelixis-eyes-oncology-deals-readies-zanzalintinib-launch-as-cabozantinib-tops-3b-2026-09-17/",
"source": "MarketBeat",
"date": "2026-09-17 11:05:01",
"summary": "Exelixis NASDAQ: EXEL President and CEO Michael Morrissey said the company is focused on expanding its oncology franchises through internal development, selective business development and potential collaborations, while preparing for a planned launch of zanzalintinib in metastati",
"image": "https://images.financialmodelingprep.com/news/exelixis-eyes-oncology-deals-readies-zanzalintinib-launch-as-cabozantinib-20260917.jpg"
},
{
"title": "Exelixis Eyes Zanza Launch as CABOMETYX Growth Faces NET Ramp Hurdle",
"url": "https://finance.yahoo.com/healthcare/articles/exelixis-eyes-zanza-launch-cabometyx-110321724.html",
"source": "Yahoo! Finance",
"date": "2026-09-15T11:03:21Z",
"summary": "* Exelixis Reports Solid Earnings -- Are New Highs Back on the Table?\n\nExelixis (NASDAQ:EXEL) executives outlined plans to continue expanding the CABOMETYX franchise while preparing for a potential launch of zanzalintinib, or zanza, in colorectal cancer later this year.\n\nSpeaking",
"image": "https://s.yimg.com/lo/mysterio/api/b00dbd8e22783bb602a2157ef4eccfc561d621b89420331da5cb7feb73806dee/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fmarketbeat_955%2Fb265eed263c7718e48ff21383e2b5d3f.jpg"
},
{
"title": "Exelixis, Inc. (EXEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946603-exelixis-inc-exel-presents-at-morgan-stanley-24th-annual-global-healthcare-conference",
"source": "Seeking Alpha",
"date": "2026-09-15 17:31:38",
"summary": "Exelixis, Inc. (EXEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/exelixis-inc-exel-presents-at-morgan-stanley-24th-annual-20260915.jpg"
},
{
"title": "Citizens reiterates Exelixis stock rating on FDA review extension By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/citizens-reiterates-exelixis-stock-rating-on-fda-review-extension-93CH-4899911",
"source": "Investing.com",
"date": "2026-09-14T14:26:45Z",
"summary": "Investing.com - Citizens reiterated a Market Outperform rating and $55.00 price target on Exelixis shares (NASDAQ:EXEL). The stock currently trades at $56.40, slightly above the target, though InvestingPro data suggests the shares may be overvalued relative to its Fair Value anal",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM431A2_1200_L.jpg"
},
{
"title": "Here's Why Exelixis (EXEL) is a Strong Growth Stock",
"url": "https://www.zacks.com/stock/news/2989122/here-s-why-exelixis-exel-is-a-strong-growth-stock?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|zacks_education_growth_score-2989122",
"source": "Zacks Investment Research",
"date": "2026-09-14 10:46:04",
"summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
"image": "https://images.financialmodelingprep.com/news/heres-why-exelixis-exel-is-a-strong-growth-stock-20260914.jpg"
},
{
"title": "Integrated Wealth Concepts LLC Has $3.19 Million Stock Holdings in Exelixis, Inc. $EXEL",
"url": "https://www.defenseworld.net/2026/09/14/integrated-wealth-concepts-llc-has-3-19-million-stock-holdings-in-exelixis-inc-exel.html",
"source": "Defense World",
"date": "2026-09-14 04:41:08",
"summary": "Integrated Wealth Concepts LLC reduced its position in shares of Exelixis, Inc. (NASDAQ: EXEL) by 25.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,636",
"image": "https://images.financialmodelingprep.com/news/integrated-wealth-concepts-llc-has-319-million-stock-holdings-20260914.jpg"
},
{
"title": "Exelixis Eyes CABOMETYX Growth, Zanzalintinib Catalysts Across Cancer Franchises",
"url": "https://www.marketbeat.com/instant-alerts/event-exelixis-eyes-cabometyx-growth-zanzalintinib-catalysts-across-cancer-franchises-2026-09-14/",
"source": "MarketBeat",
"date": "2026-09-14 04:02:08",
"summary": "Exelixis NASDAQ: EXEL executives outlined a franchise-focused growth strategy centered on expanding CABOMETYX across renal cell carcinoma and neuroendocrine tumors while advancing zanzalintinib through multiple late-stage studies.",
"image": "https://images.financialmodelingprep.com/news/exelixis-eyes-cabometyx-growth-zanzalintinib-catalysts-across-cancer-franchises-20260914.jpg"
},
{
"title": "Exelixis: The FDA Delay Costs Less Than The Market Thinks",
"url": "https://seekingalpha.com/article/4945892-exelixis-stock-fda-delay-costs-less-than-market-thinks",
"source": "Seeking Alpha",
"date": "2026-09-14 01:15:45",
"summary": "The FDA extended its review of Exelixis' zanzalintinib by three months, but no new clinical failure or safety signal was disclosed. At a 10% discount rate, three months reduces an asset's present value by only 2.35%, far less than Exelixis initially lost. CABOMETYX continues grow",
"image": "https://images.financialmodelingprep.com/news/exelixis-the-fda-delay-costs-less-than-the-market-20260914.jpg"
},
{
"title": "Why is Exelixis stock sliding today? By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/why-is-exelixis-stock-sliding-today-93CH-4897959",
"source": "Investing.com",
"date": "2026-09-11T13:01:44Z",
"summary": "Investing.com -- Shares of Exelixis fell 3.5% in pre-open trading after the U.S. Food and Drug Administration extended its review of the company's new drug application for zanzalintinib in combination with atezolizumab for metastatic colorectal cancer by three months. The agency ",
"image": "https://content-media.investing.com/news/LYNXNPEC0Q0MJ_L.jpg"
},
{
"title": "Exelixis stock falls as FDA extends zanzalintinib review By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/exelixis-stock-falls-as-fda-extends-zanzalintinib-review-93CH-4897925",
"source": "Investing.com",
"date": "2026-09-11T12:52:51Z",
"summary": "Investing.com -- Exelixis Inc (NASDAQ:EXEL) shares fell 3.5% in premarket trading Friday after the company disclosed that the FDA extended the review period for its cancer drug candidate by three months.\n\nThe FDA notified Exelixis on September 10, 2026, that it had extended the r",
"image": "https://content-media.investing.com/news/LYNXNPEC0K08U_L.jpg"
},
{
"title": "Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In",
"url": "https://www.benzinga.com/news/fda/26/09/61747592/exelixis-stock-slips-as-fda-delays-cancer-drug-review-analyst-weighs-in",
"source": "Benzinga",
"date": "2026-09-11 14:02:50",
"summary": "On Friday, the U.S. Food and Drug Administration (FDA) extended the review period for Exelixis Inc.\u2018s (NASDAQ:EXEL) new drug application (NDA) for zanzalintinib, in combination with atezolizumab, for metastatic colorectal cancer by three months.",
"image": "https://images.financialmodelingprep.com/news/exelixis-stock-slips-as-fda-delays-cancer-drug-review-20260911.jpg"
},
{
"title": "U.S. FDA extends review of Exelixis' cancer drug",
"url": "https://www.reuters.com/legal/litigation/us-fda-extends-review-exelixis-cancer-drug-2026-09-11/",
"source": "Reuters",
"date": "2026-09-11 07:30:38",
"summary": "The \u200cU.S. Food and Drug Administration has extended the review of \u200bExelixis' experimental colorectal \u200bcancer drug combination by three \u2060months, the company said \u200bin a filing on \u200bFriday.",
"image": "https://images.financialmodelingprep.com/news/us-fda-extends-review-of-exelixis-cancer-drug-20260911.jpg"
},
{
"title": "Baird Financial Group Inc. Raises Holdings in Exelixis, Inc. $EXEL",
"url": "https://www.defenseworld.net/2026/09/11/baird-financial-group-inc-raises-holdings-in-exelixis-inc-exel.html",
"source": "Defense World",
"date": "2026-09-11 04:30:57",
"summary": "Baird Financial Group Inc. increased its holdings in shares of Exelixis, Inc. (NASDAQ: EXEL) by 7,459.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 437,138 shares of the biotechnology compan",
"image": "https://images.financialmodelingprep.com/news/baird-financial-group-inc-raises-holdings-in-exelixis-inc-20260911.jpg"
},
{
"title": "Exelixis, Inc. (EXEL) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript",
"url": "https://seekingalpha.com/article/4944713-exelixis-inc-exel-presents-at-citigroups-biopharma-back-to-school-summit-2026-transcript",
"source": "Seeking Alpha",
"date": "2026-09-09 17:57:16",
"summary": "Exelixis, Inc. (EXEL) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/exelixis-inc-exel-presents-at-citigroups-biopharma-back-to-20260909.jpg"
},
{
"title": "Exelixis, Inc. (EXEL) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4944012-exelixis-inc-exel-presents-at-wells-fargo-21st-annual-healthcare-conference-transcript",
"source": "Seeking Alpha",
"date": "2026-09-08 14:55:31",
"summary": "Exelixis, Inc. (EXEL) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/exelixis-inc-exel-presents-at-wells-fargo-21st-annual-20260908.jpg"
},
{
"title": "Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?",
"url": "https://www.zacks.com/stock/news/2985336/exelixis-exel-up-13-3-since-last-earnings-report-can-it-continue?cid=CS-STOCKNEWSAPI-FT-realtime_blog-2985336",
"source": "Zacks Investment Research",
"date": "2026-09-04 12:37:35",
"summary": "Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock?",
"image": "https://images.financialmodelingprep.com/news/exelixis-exel-up-133-since-last-earnings-report-can-20260904.jpg"
},
{
"title": "Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?",
"url": "https://www.zacks.com/stock/news/2984350/exelixis-exel-is-a-top-ranked-value-stock-should-you-buy?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|zacks_education_value_score-2984350",
"source": "Zacks Investment Research",
"date": "2026-09-03 10:41:17",
"summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
"image": "https://images.financialmodelingprep.com/news/exelixis-exel-is-a-topranked-value-stock-should-you-20260903.jpg"
},
{
"title": "Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September",
"url": "https://www.businesswire.com/news/home/20260901665495/en/Exelixis-to-Webcast-Fireside-Chats-as-Part-of-Upcoming-Investor-Conferences-in-September/",
"source": "Business Wire",
"date": "2026-09-01 16:05:00",
"summary": "ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in September: Wells Fargo 21st Annual Healthcare Conference: Exelixis is scheduled to present at 11:00 ",
"image": "https://images.financialmodelingprep.com/news/exelixis-to-webcast-fireside-chats-as-part-of-upcoming-20260901.jpg"
},
{
"title": "Exelixis Owners Keep Getting A Bigger Slice Of A Company In Transition",
"url": "https://finance.yahoo.com/markets/stocks/articles/exelixis-owners-keep-getting-bigger-183610090.html",
"source": "Yahoo! Finance",
"date": "2026-08-24T18:36:10Z",
"summary": "A buyback funded by one oncology drug is concentrating each holder's claim while the next franchise waits on a regulatory decision.\n\nExelixis (EXEL) has gained 42.8% over the past twelve months and trades about 5% below its 52-week high, so this is not a stock the market has give",
"image": "https://s.yimg.com/lo/mysterio/api/8747f7cd1697d4525402529f5891ca6469beabd3370390f8ce5ac8f9c784e25b/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Ftrefis_142%2Ff32250d44f592b9d1ed623b4067b2431.jpg"
},
{
"title": "BMO initiates Exelixis stock at Market Perform, cites patent cliff By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/bmo-initiates-exelixis-stock-at-market-perform-cites-patent-cliff-93CH-4866918",
"source": "Investing.com",
"date": "2026-08-19T10:24:50Z",
"summary": "Investing.com - BMO Capital initiated coverage on Exelixis Inc. (NASDAQ:EXEL) with a Market Perform rating and a price target of $54.00, the firm said Tuesday.\n\nThe commercial-stage oncology company is anchored by cabozantinib, which generated approximately $2.12 billion in fisca",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3S10Z_1200_L.jpg"
},
{
"title": "Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm",
"url": "https://www.globenewswire.com/news-release/2026/07/29/3335687/0/en/Kuehn-Law-Encourages-Investors-of-EXELIXIS-Inc-to-Contact-Law-Firm.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-29T22:56:00Z",
"summary": "Kuehn Law is investigating whether officers and directors of EXELIXIS, Inc. breached fiduciary duties to shareholders through potential self-dealing. The firm is seeking long-term EXEL stockholders to participate in shareholder litigation, offering free consultations with no obli",
"image": "https://ml.globenewswire.com/Resource/Download/83bde11e-8ae3-488a-a2c9-2ce956c44090"
},
{
"title": "Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/06/10/3310000/0/en/Metastatic-Prostate-Cancer-Market-Set-for-Robust-Growth-Through-2036-Driven-by-The-Emergence-of-PARP-Inhibitors-and-PSMA-targeted-Radioligand-Therapies-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-10T17:00:00Z",
"summary": "The metastatic prostate cancer market is projected to experience robust growth through 2036, valued at USD 11.5 billion in 2025 across seven major markets. The market is transitioning from conventional androgen deprivation therapy toward combination-based, biomarker-driven approa",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
},
{
"title": "Prediction: This Stock Could Double By 2031",
"url": "https://www.fool.com/investing/2026/05/15/prediction-this-stock-could-double-by-2031/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-05-15T23:30:00Z",
"summary": "Exelixis, a biotech company focused on cancer medicines, could potentially double by 2031. While its main product Cabometyx will face generic competition by early 2030, the company's promising pipeline candidate zanzalintinib could reach peak sales of $5 billion across multiple c",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F869649%2Fexelixis-logo.png&w=1200&op=resize"
},
{
"title": "Why Is Merck Stock Falling Tuesday?",
"url": "https://www.benzinga.com/markets/biotech/26/04/51949696/why-is-merck-stock-falling-tuesday?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-04-21T17:42:25Z",
"summary": "Merck & Co. and Eisai announced that their Phase 3 LITESPARK-012 trial failed to meet primary endpoints for a triplet therapy combining Keytruda, Lenvima, and Welireg for advanced clear cell renal cell carcinoma. The failure caused Merck shares to fall 4.08%. However, the FDA app",
"image": "https://cdn.benzinga.com/files/images/story/2026/04/21/South-San-Francisco--Ca--Usa---May-1--20.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "The Best Healthcare Stocks to Buy With $50 Right Now",
"url": "https://www.fool.com/investing/2026/03/18/the-best-healthcare-stocks-to-buy-with-50-right-no/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-03-18T12:30:00Z",
"summary": "The article recommends three healthcare stocks trading under $50: Pfizer (PFE) at $27.45 with a low forward P/E of 9x and a strong oncology pipeline; Novo Nordisk (NVO) at $38.43 positioned to capitalize on the expanding weight-loss drug market with products like Wegovy; and Exel",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F859767%2Fresearch-scientists-drugs-pharma-biotech.jpg&w=1200&op=resize"
}
]
Data:
[
{
"symbol": "EXEL",
"date": "2026-11-03",
"epsActual": null,
"epsEstimated": 0.89,
"revenueActual": null,
"revenueEstimated": 649571100,
"lastUpdated": "2026-09-18"
},
{
"symbol": "EXEL",
"date": "2026-08-05",
"epsActual": 0.91,
"epsEstimated": 0.853,
"revenueActual": 628690000,
"revenueEstimated": 636396900,
"lastUpdated": "2026-09-18"
},
{
"symbol": "EXEL",
"date": "2026-05-05",
"epsActual": 0.87,
"epsEstimated": 0.765,
"revenueActual": 610812000,
"revenueEstimated": 607508500,
"lastUpdated": "2026-08-05"
},
{
"symbol": "EXEL",
"date": "2026-02-10",
"epsActual": 0.94,
"epsEstimated": 0.77,
"revenueActual": 598663000,
"revenueEstimated": 596524100,
"lastUpdated": "2026-05-10"
},
{
"symbol": "EXEL",
"date": "2025-11-04",
"epsActual": 0.78,
"epsEstimated": 0.685,
"revenueActual": 597755000,
"revenueEstimated": 590162524,
"lastUpdated": "2026-02-03"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "EXEL",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "EXEL",
"periods": [
{
"file_period": "202606a",
"settlement_date": "20260604",
"quantity_fails": 57234,
"price": 51.6
},
{
"file_period": "202606b",
"settlement_date": "20260615",
"quantity_fails": 32,
"price": 53.13
},
{
"file_period": "202607a",
"settlement_date": "20260713",
"quantity_fails": 166,
"price": 56.5
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 619,
"price": 55.97
},
{
"file_period": "202608a",
"settlement_date": "20260812",
"quantity_fails": 479,
"price": 51.33
},
{
"file_period": "202608b",
"settlement_date": "20260825",
"quantity_fails": 1,
"price": 54.55
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "EXEL",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0001520181",
"companyCik": "0000939767",
"transactionType": "S-Sale",
"securitiesOwned": 16079,
"reportingName": "Beckerle Mary C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9812,
"price": 53.66,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000101/0000939767-26-000101-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-06-03",
"transactionDate": "2026-06-01",
"reportingCik": "0001023225",
"companyCik": "0000939767",
"transactionType": "S-Sale",
"securitiesOwned": 284384,
"reportingName": "WYSZOMIERSKI JACK L",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3925,
"price": 50.55,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000085/0000939767-26-000085-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-06-03",
"transactionDate": "2026-06-01",
"reportingCik": "0001823769",
"companyCik": "0000939767",
"transactionType": "S-Sale",
"securitiesOwned": 16079,
"reportingName": "Eckhardt Sue Gail",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9812,
"price": 50.14,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000084/0000939767-26-000084-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-05-29",
"transactionDate": "2026-05-27",
"reportingCik": "0001202098",
"companyCik": "0000939767",
"transactionType": "A-Award",
"securitiesOwned": 1197595,
"reportingName": "PAPADOPOULOS STELIOS",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8367,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000083/0000939767-26-000083-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-05-29",
"transactionDate": "2026-05-27",
"reportingCik": "0001814673",
"companyCik": "0000939767",
"transactionType": "A-Award",
"securitiesOwned": 50649,
"reportingName": "Heyman Tomas J.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8367,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000082/0000939767-26-000082-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-05-29",
"transactionDate": "2026-05-27",
"reportingCik": "0001823769",
"companyCik": "0000939767",
"transactionType": "A-Award",
"securitiesOwned": 25891,
"reportingName": "Eckhardt Sue Gail",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8367,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000081/0000939767-26-000081-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-05-29",
"transactionDate": "2026-05-27",
"reportingCik": "0001557928",
"companyCik": "0000939767",
"transactionType": "A-Award",
"securitiesOwned": 28957,
"reportingName": "Smith Julie",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8367,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000080/0000939767-26-000080-index.htm"
},
{
"symbol": "EXEL",
"filingDate": "2026-05-29",
"transactionDate": "2026-05-27",
"reportingCik": "0001547999",
"companyCik": "0000939767",
"transactionType": "A-Award",
"securitiesOwned": 109186,
"reportingName": "Freire Maria C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8367,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/939767/000093976726000079/0000939767-26-000079-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "EXEL",
"senateID": "K000389",
"disclosureDate": "2024-02-05",
"transactionDate": "2024-01-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Exelixis Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220127.pdf"
},
{
"symbol": "EXEL",
"senateID": "K000389",
"disclosureDate": "2023-01-03",
"transactionDate": "2022-12-06",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Exelixis Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219318.pdf"
},
{
"symbol": "EXEL",
"senateID": "S001206",
"disclosureDate": "2020-04-27",
"transactionDate": "2019-06-04",
"firstName": "Donna",
"lastName": "Shalala",
"office": "Donna Shalala",
"district": "FL27",
"owner": "",
"assetDescription": "Exelixis, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016481.pdf"
},
{
"symbol": "EXEL",
"senateID": "S001206",
"disclosureDate": "2020-04-27",
"transactionDate": "2019-04-16",
"firstName": "Donna",
"lastName": "Shalala",
"office": "Donna Shalala",
"district": "FL27",
"owner": "",
"assetDescription": "Exelixis, Inc.",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016481.pdf"
},
{
"symbol": "EXEL",
"senateID": "S001206",
"disclosureDate": "2020-04-27",
"transactionDate": "2019-02-06",
"firstName": "Donna",
"lastName": "Shalala",
"office": "Donna Shalala",
"district": "FL27",
"owner": "",
"assetDescription": "Exelixis, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016481.pdf"
},
{
"symbol": "EXEL",
"senateID": "S001206",
"disclosureDate": "2020-04-27",
"transactionDate": "2019-01-09",
"firstName": "Donna",
"lastName": "Shalala",
"office": "Donna Shalala",
"district": "FL27",
"owner": "",
"assetDescription": "Exelixis, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016481.pdf"
}
],
"dark_pool": [
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:01.046000Z",
"size": 37160.0,
"price": 58.49,
"premium": 2173488.4,
"volume": 37160.0,
"trade_code": "6"
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:01.047000Z",
"size": 31005.0,
"price": 58.49,
"premium": 1813482.45,
"volume": 31005.0,
"trade_code": "6"
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:01.046000Z",
"size": 15335.0,
"price": 58.49,
"premium": 896944.15,
"volume": 15335.0,
"trade_code": "6"
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:33.075000Z",
"size": 7939.0,
"price": 58.49,
"premium": 464352.11000000004,
"volume": 7939.0,
"trade_code": " "
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:33.067000Z",
"size": 5285.0,
"price": 58.49,
"premium": 309119.65,
"volume": 5285.0,
"trade_code": " "
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:01.046000Z",
"size": 3826.0,
"price": 58.49,
"premium": 223782.74000000002,
"volume": 3826.0,
"trade_code": "6"
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:01.046000Z",
"size": 3770.0,
"price": 58.49,
"premium": 220507.30000000002,
"volume": 3770.0,
"trade_code": "6"
},
{
"ticker": "EXEL",
"executed_at": "2026-09-17T20:00:01.046000Z",
"size": 3400.0,
"price": 58.49,
"premium": 198866.0,
"volume": 3400.0,
"trade_code": "6"
}
],
"ats": {
"symbol": "EXEL",
"date": "20260917",
"ats_volume": 0,
"total_volume": 533357,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260917",
"ats_ratio": 0.0
},
{
"date": "20260916",
"ats_ratio": 0.0
},
{
"date": "20260915",
"ats_ratio": 0.0
},
{
"date": "20260914",
"ats_ratio": 0.0
},
{
"date": "20260911",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "EXEL",
"days": [
{
"date": "2026-09-17",
"close": 58.49,
"vwap": 58.18,
"volume": 1785586,
"vwap_discount_pct": -0.53
},
{
"date": "2026-09-16",
"close": 56.78,
"vwap": 57.0,
"volume": 1879641,
"vwap_discount_pct": 0.39
},
{
"date": "2026-09-15",
"close": 56.9,
"vwap": 56.45,
"volume": 1980448,
"vwap_discount_pct": -0.79
},
{
"date": "2026-09-14",
"close": 56.21,
"vwap": 56.3,
"volume": 1739463,
"vwap_discount_pct": 0.17
},
{
"date": "2026-09-11",
"close": 56.12,
"vwap": 56.1,
"volume": 2916863,
"vwap_discount_pct": -0.04
}
],
"avg_vwap_discount_pct": -0.16,
"signal": "Distribution"
},
"options_flow": [],
"net_premium": {
"ticker": "EXEL",
"net_call_premium": "-8697.00",
"net_put_premium": "-5157.00",
"call_premium": "94517.00",
"put_premium": "9877.00",
"bullish_premium": "49637.00",
"bearish_premium": "53177.00",
"put_call_ratio": "0.144186046511627906976744186",
"iv_rank": "30.894",
"implied_move_perc": "0.072",
"gex_ratio": "1.1185056823197286",
"gex_net_change": "-2087.0320",
"gex_call": "72031.7088",
"gex_put": "-80567.8756",
"gex_net": -8536.1668,
"gex_call_delta": "1088501.7451",
"gex_put_delta": "-469005.0334",
"gex_date": "2026-09-17"
},
"hot_chains": [
{
"underlying_symbol": "EXEL",
"expires": "2026-10-16",
"open_interest": 163,
"option_type": "call",
"delta": 0.408567178654481,
"ask_volume": 69,
"last_price": "1.70",
"implied_volatility": "0.3545954513464655",
"gamma": 0.0722225343124404,
"avg_price": "1.5928252788104089219330855022",
"bid_volume": 198,
"nbbo_ask": "1.80",
"strike": "60",
"option_symbol": "EXEL261016C00060000",
"total_premium": "42847.00",
"iv": 0.326205679316819,
"volume": 269,
"nbbo_bid": "1.40"
},
{
"underlying_symbol": "EXEL",
"expires": "2026-09-18",
"open_interest": 3729,
"option_type": "call",
"delta": 0.121371573178127,
"ask_volume": 20,
"last_price": "0.10",
"implied_volatility": "0.460223822507891",
"gamma": 0.159464506791482,
"avg_price": "0.1081250000000000000000000000",
"bid_volume": 8,
"nbbo_ask": "0.10",
"strike": "60",
"option_symbol": "EXEL260918C00060000",
"total_premium": "519.00",
"iv": 0.413010070325837,
"volume": 48,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "EXEL",
"expires": "2027-01-15",
"open_interest": 443,
"option_type": "call",
"delta": 0.490194745097316,
"ask_volume": 24,
"last_price": "4.60",
"implied_volatility": "0.3838160996553399",
"gamma": 0.0336663515481472,
"avg_price": "4.6000000000000000000000000000",
"bid_volume": 10,
"nbbo_ask": "5.10",
"strike": "60",
"option_symbol": "EXEL270115C00060000",
"total_premium": "15640.00",
"iv": 0.353167995291826,
"volume": 34,
"nbbo_bid": "3.70"
},
{
"underlying_symbol": "EXEL",
"expires": "2026-09-18",
"open_interest": 463,
"option_type": "call",
"delta": 0.99958635341449,
"ask_volume": 16,
"last_price": "3.10",
"implied_volatility": "0.527261118209055",
"gamma": 0.00138137125467227,
"avg_price": "3.0003448275862068965517241379",
"bid_volume": 13,
"nbbo_ask": "3.80",
"strike": "55",
"option_symbol": "EXEL260918C00055000",
"total_premium": "8701.00",
"iv": 0.352490539189314,
"volume": 29,
"nbbo_bid": "1.25"
},
{
"underlying_symbol": "EXEL",
"expires": "2026-10-16",
"open_interest": 10544,
"option_type": "put",
"delta": -0.104163880406335,
"ask_volume": 20,
"last_price": "0.30",
"implied_volatility": "0.4216887338324615",
"gamma": 0.0235002577145406,
"avg_price": "0.6009090909090909090909090908",
"bid_volume": 2,
"nbbo_ask": "0.55",
"strike": "50",
"option_symbol": "EXEL261016P00050000",
"total_premium": "1322.00",
"iv": 0.466612129492475,
"volume": 22,
"nbbo_bid": "0"
},
{
"underlying_symbol": "EXEL",
"expires": "2026-10-16",
"open_interest": 3640,
"option_type": "put",
"delta": -0.28780925892298,
"ask_volume": 0,
"last_price": "1.53",
"implied_volatility": "0.456122902967569",
"gamma": 0.0472064679720679,
"avg_price": "1.53",
"bid_volume": 20,
"nbbo_ask": "2.60",
"strike": "55",
"option_symbol": "EXEL261016P00055000",
"total_premium": "3060.00",
"iv": 0.43825355320857,
"volume": 20,
"nbbo_bid": "0"
},
{
"underlying_symbol": "EXEL",
"expires": "2026-12-18",
"open_interest": 323,
"option_type": "call",
"delta": 0.485206273274195,
"ask_volume": 2,
"last_price": "3.72",
"implied_volatility": "0.3721437640944353",
"gamma": 0.0355523262300799,
"avg_price": "3.7466666666666666666666666667",
"bid_volume": 15,
"nbbo_ask": "5.90",
"strike": "60",
"option_symbol": "EXEL261218C00060000",
"total_premium": "6744.00",
"iv": 0.381782067217931,
"volume": 18,
"nbbo_bid": "2.55"
},
{
"underlying_symbol": "EXEL",
"expires": "2026-10-16",
"open_interest": 122,
"option_type": "call",
"delta": 0.126341354234267,
"ask_volume": 2,
"last_price": "0.60",
"implied_volatility": "0.3975304405474039",
"gamma": 0.0399246848845773,
"avg_price": "0.4714285714285714285714285714",
"bid_volume": 1,
"nbbo_ask": "0.65",
"strike": "65",
"option_symbol": "EXEL261016C00065000",
"total_premium": "330.00",
"iv": 0.31507619998718,
"volume": 7,
"nbbo_bid": "0.20"
}
],
"gamma_profile": {
"ticker": "EXEL",
"spot": 58.49,
"date": "2026-09-17",
"flip_point": 39.03,
"net_gex": -8536.17,
"call_walls": [
{
"strike": 60.0,
"gex": 41321.68
},
{
"strike": 55.0,
"gex": 10550.57
},
{
"strike": 50.0,
"gex": 7507.03
}
],
"put_walls": [
{
"strike": 50.0,
"gex": -44042.03
},
{
"strike": 55.0,
"gex": -26433.41
},
{
"strike": 40.0,
"gex": -6101.21
}
],
"by_strike": [
{
"strike": 40.0,
"call_gex": 553.98,
"put_gex": -6101.21,
"net_gex": -5547.24
},
{
"strike": 41.0,
"call_gex": 26.35,
"put_gex": -12.37,
"net_gex": 13.98
},
{
"strike": 42.0,
"call_gex": 790.23,
"put_gex": -34.67,
"net_gex": 755.56
},
{
"strike": 43.0,
"call_gex": 45.69,
"put_gex": -0.89,
"net_gex": 44.8
},
{
"strike": 44.0,
"call_gex": 31.75,
"put_gex": -14.37,
"net_gex": 17.38
},
{
"strike": 45.0,
"call_gex": 1466.21,
"put_gex": -693.74,
"net_gex": 772.48
},
{
"strike": 46.0,
"call_gex": 16.17,
"put_gex": -11.22,
"net_gex": 4.95
},
{
"strike": 47.0,
"call_gex": 71.79,
"put_gex": -169.77,
"net_gex": -97.98
},
{
"strike": 48.0,
"call_gex": 645.49,
"put_gex": -733.51,
"net_gex": -88.02
},
{
"strike": 49.0,
"call_gex": 125.12,
"put_gex": -9.84,
"net_gex": 115.28
},
{
"strike": 50.0,
"call_gex": 7507.03,
"put_gex": -44042.03,
"net_gex": -36535.0
},
{
"strike": 55.0,
"call_gex": 10550.57,
"put_gex": -26433.41,
"net_gex": -15882.85
},
{
"strike": 60.0,
"call_gex": 41321.68,
"put_gex": -2035.87,
"net_gex": 39285.81
},
{
"strike": 65.0,
"call_gex": 6369.1,
"put_gex": -3.0,
"net_gex": 6366.1
},
{
"strike": 70.0,
"call_gex": 1439.19,
"put_gex": -2.31,
"net_gex": 1436.88
},
{
"strike": 75.0,
"call_gex": 533.5,
"put_gex": 0.0,
"net_gex": 533.5
},
{
"strike": 80.0,
"call_gex": 67.16,
"put_gex": 0.0,
"net_gex": 67.16
},
{
"strike": 85.0,
"call_gex": 30.76,
"put_gex": 0.0,
"net_gex": 30.76
}
]
},
"oi_changes": {
"net_call_oi_change": 38,
"net_put_oi_change": 0,
"top": [
{
"strike": "60",
"oi_change": 40,
"type": "call"
},
{
"strike": "50",
"oi_change": -1,
"type": "put"
},
{
"strike": "55",
"oi_change": 1,
"type": "put"
},
{
"strike": "55",
"oi_change": -1,
"type": "call"
},
{
"strike": "50",
"oi_change": -1,
"type": "call"
}
]
},
"opds": {
"opds": -4.2,
"D": -16.6,
"P": 47.1,
"O": 14.0,
"C": 25.4,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.85,
"ranked": true,
"components": {
"M": 54.0,
"T": 58.5,
"RS": 34.8,
"V": 33.0,
"F": -3.4,
"OI": 100.0,
"S": -100.0,
"IV": 100.0,
"B": null,
"Liquidity": 9.0,
"OpeningConfidence": null,
"FlowAgreement": 50.0,
"StrikeBreadth": null
},
"drivers": [
"+ open-interest change +100",
"- skew -100",
"+ IV behaviour +100",
"+ trend +59",
"+ momentum +54"
]
}
}
Data:
{
"vix": 17.1,
"sp500": 7585.73,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.33,
"hy_spread": 2.65,
"treasury": {
"date": "2026-09-16",
"month1": 3.96,
"month2": 4.07,
"month3": 4.14,
"month6": 4.22,
"year1": 4.45,
"year2": 4.74,
"year3": 4.82,
"year5": 4.86,
"year7": 4.94,
"year10": 5.01,
"year20": 5.39,
"year30": 5.35
},
"events": []
}
Data:
{
"days": 104,
"patterns": [
{
"name": "VWAP Touch",
"count": 104,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 104,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 104,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 101,
"pct": 97
},
{
"name": "ORB Breakout",
"count": 97,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 85,
"pct": 82
},
{
"name": "Open Retracement",
"count": 73,
"pct": 70
},
{
"name": "Gap Fill",
"count": 71,
"pct": 68
},
{
"name": "Darvas Box",
"count": 31,
"pct": 30
},
{
"name": "High Vol Open",
"count": 20,
"pct": 19
},
{
"name": "Power Hour",
"count": 10,
"pct": 10
}
]
}